Registry for bone cancer patients to share health information
Part of Bones, joints & muscles, Cancer clinical trials.
This trial is a registry that collects health and medical history from people with osteosarcoma and related bone cancers. It may help researchers learn how these cancers behave and support better future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have osteosarcoma or a closely related bone cancer
- Your diagnosis is high-grade or specific less-common types listed by the study
- You (or your guardian) can give informed consent to join
- You understand you’re joining an information-collection registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on improving how osteosarcoma care is coordinated and delivered, using collaboration between clinicians. It may help by helping teams make more consistent treatment decisions for people newly diagnosed.
This study asks people with osteosarcoma about what it’s like to join and participate in clinical trials. It may help improve how future trials are explained and run.
This study is watching people whose high-grade osteosarcoma came back in the same bone area (local relapse) after treatment. It helps doctors understand how local relapse happens, so they can improve future care.
This study looks at how well people heal and how well they can move and use the repaired bone after reconstructive surgery for bone tumors. It may help doctors understand what recovery looks like and what could improve function over time.
This trial studies whether regorafenib given after first treatment helps patients with bone sarcoma stay in remission longer. It focuses on safety and whether the medicine can prevent the cancer from growing or returning.
This trial is a health registry that collects information about people with soft-tissue or bone sarcoma. It helps researchers understand how the disease behaves and what outcomes different treatments lead to.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.